Current calls, week 38, 2024

Forskningsanslag - Familjen Kamprads Stiftelse

Stiftelsen utlyser 150 miljoner kronor till forskning i två områden:

En bättre miljö

Stiftelsen välkomnar projektansökningar som fokuserar på miljöproblem som är särskilt svåra att lösa för att de inbegriper många aktörer och sektorer.

Förbättrad livskvalitet för äldre

Stiftelsen välkomnar projektansökningar med fokus på aspekter som bidrar till ett gott liv för den åldrande befolkningen, till exempel trygghet, välfärdsteknik, inflytande, anhöriga/ närstående, kvalitet på vård och omsorg, rättssäkerhet och driftsform.

Ansökningsprocessen är indelad i två steg.

Closing date: October 1, 2024 (stage 1). Stage 2 is open between November 12 and December 12, 2024.

Postdoc Program - SciLifeLab at Karolinska Institutet

The Strategic Research Area for SciLifeLab at Karolinska Institutet funds postdoc grants in collaborative projects between researchers at SciLifeLab and clinical scientists. The postdocs in the program form the KI-SciLifeLab Clinical Translational Postdoc Network. There are currently several opportunities for talented researchers to join this program:

2-year Postdoctoral Position in Plasma Epigenomics within KI-SciLifeLab Clinical Translational Postdoc Network

Closing date: October 2, 2024

Postdoctoral Researcher in Immunology and Spatial transcriptomics
Postdoctoral position in translational hematology and multi-omics
Postdoctoral Researcher in Molecular Cancer Therapy

Closing date: October 9, 2024

Postdoctoral Researcher in in phage biology and antimicrobial resistance

Closing date: October 31, 2024

Nobel symposia - The Royal Swedish Academy of Sciences, and the Knut and Alice Wallenberg Foundation

Applications are invited for grants to organise Nobel symposia in physics, chemistry, physiology or medicine, economic sciences, and literature, to bring Swedish researchers in direct contact with international researchers. Symposia may involve up to 50 participants and last between three to five days. A majority of the active participants should come from academic institutions in non-Nordic countries. It is desirable that a limited number of younger researchers are given a chance to follow parts of the Nobel Symposium as participants or observers, and that part of the symposium is an open session. The total amount requested for a Nobel Symposium must not exceed 950,000 SEK.

Closing date: October 11, 2024

Forskningsanslag - Fredrik och Ingrid Thurings Stiftelse

Ändamålet är begränsat till att avse psykiatrisk forskning, både med inriktning på barn och ungdomar och avseende vuxna. Klinisk forskning ges prioritet. Behöriga att söka är forskare som ännu ej disputerat eller disputerade forskare där det har gått högst 5 år sedan avhandlingens försvar. . Bidrag är värda mellan SEK 50,000 och SEK 300,000.

Closing date: October 15, 2023

Research projects - Professor Nanna Svartz Fond

Fond supports research in internal medicine.

Closing date: October 15, 2024

Forskningsanslag och stipendier - Stiftelsen Samariten

Stiftelsen utdelar medel till forskningsprojekt och undervisning främst inom den medicinska barnavården. De som befinner sig i början av sin forskningskarriär, dvs blivande doktorander, doktorander och postdoktorer, samt projekt utan andra stora anslag prioriteras

Closing date: October 20, 2024

Forskningsstipendier - Apotekarsocieteten

Apotekarsocieteten utlyser stipendier med syfte att främja vetenskapliga studier och forskning som täcker olika typer av farmaceutisk forskning från tidig läkemedelsutveckling till läkemedelsanvändning. Stipendier kan sökas för:

Deltagande i forskarkurser, konferenser mm
Examensarbete utomlands
Forskningsvistelse vid annat universitet eller i annan forskningsmiljö
Post doc-stipendier

Closing date: October 31, 2024

Forskningsanslag - Percy Falks Stiftelse

Främjar vetenskaplig forskning och undervisning eller studieverksamhet i Sverige rörande prostatacancer och bröstcancer.

Closing date: November 1, 2024

Inbjudan att nominera till Hilda och Alfred Erikssons pris år 2025

Priset utdelas årligen som belöning för framstående forskningsinsatser för lindring av sjukdomar hos människor och djur. Mottagaren av priset ska vara svensk medborgare.

Closing date: October 1, 2024

Nomineringsblankett

Läromedelsförfattarna - kopieringsstipendium för författare av kurslitteratur och läromedel

Du som har skrivit eller översatt läromedel eller kurslitteratur kan få vårt kopieringsstipendium. Det gäller oavsett om du är ensam författare till ett helt verk, skrivit i ett team eller om du bara har skrivit enstaka kapitel. Du behöver inte vara medlem i Läromedelsförfattarna för att få detta stipendium.

Closing date: October 15, 2024

European calls

Young Inventors Prize and European Inventor Award

The Young Inventor Prize, now with a new format, aims to spotlight change makers and reward younger generations for their creative solutions to global challenges. The Prize also presents an opportunity to recognise top talent and showcase the ingenuity of inventors in your professional network. In terms of eligibility requirements, patents are not a prerequisite, the Prize is open to inventors worldwide and there are no limits on how many entries you may submit.

Closing date: September 27, 2024

Call for proposals on patient-centered and patient-driven care in rheumatic and musculoskeletal disorders - Foundation for Research in Rheumatology (FOREUM)

The Foundation for Research in Rheumatology invites applications for its call for proposals on patient-centered and patient-driven care in rheumatic and musculoskeletal disorders. This supports research proposals focused on developing and implementing scientific research-based patient-centred and patient-driven approaches to improve the care and well-being of individuals living with RMDs. This call aims to stimulate impactful scientific research that revolutionizes the way care is delivered, ensuring that it is tailored to individual needs and supports long-term sustainability. Scientific proposals that address the following areas are encouraged:

•patient-centred care;

•patient-driven approaches;

•sustainable care models.

Applications must involve partners from at least three different countries. Any given institution shall be allowed to lead on only one application. However, that institution, or its staff may participate in other projects as collaborators. The call shall be open to participants from EULAR membership countries. The Principal Investigator should come from a EULAR membership country. Centres from non-EULAR membership countries can participate as partners in exceptional cases, but will not be eligible to receive research funding. Members of the FOREUM committees and EULAR Executive Committee are not allowed to submit or to participate in applications.

An individual proposal may be funded with up to a maximal amount of €600.000 for a three-year funding period.

Deadline: The call will be launced on 23 September 2024. Anticipated deadline 05 Nov 2024.

Digital and Computational Pathology Fellowship - European Society for Medical Oncology (ESMO)

The ESMO Digital and Computational Pathology Fellowship intends to help physicians who wish to play a role in the field of digital and computational pathology.

Aims of the ESMO Digital and Computational Pathology Fellowship:

To discover new solutions and potentially new methods that can be applied to digital and computational pathology.
To run projects and develop collaborations that will facilitate implementation of digital and computational pathology in daily practice and in a broader way in the field of oncology.
The fellow will have the opportunity to be paired with a member of the ESMO Faculty corresponding to their field of research.

The fellowship has a duration of two years and will provide 200,000 euros to supplement the salary of one fellow for the entire duration of the fellowship.

Deadline: 17 November 2024, 12.00 am CET

Scientific call for proposals - Association Francaise Contre les Myopathies (AFM) (French Muscular Dystrophy Association)

The French Muscular Dystrophy Association invites applications for its scientific call for proposals. This aims to increase understanding of the neuromuscular system and encourage the development of therapies for neuromuscular diseases and rare genetic diseases. The following grants are available:

trampoline grants are meant to support young investigators early in their professional career or early-stage innovative projects - grants are worth up to €50,000 for one year;
research grants are open to researchers or clinical investigators holding a permanent position or equivalent in an academic, governmental or private institution, with proposals from groups outside France strongly encouraged to include a French component - grants last one year and are renewable for a second, and exceptionally for a third;
postdoctoral fellowships are open to candidates who have defended their doctoral thesis before the payment of the fellowship - fellowships last for one year and are renewable for a second.

Deadline: 21 January 2025

Research grant - Italian Cystic Fibrosis Research Foundation

The Italian Cystic Fibrosis Research Foundation invites applications for its research grant. This supports research projects aiming to improve the health status of cystic fibrosis patients. Research projects dealing with either clinical studies or pre-clinical studies exploiting animal models of CF are strongly encouraged. Priority areas include:

Innovative studies and therapies to correct CFTR basic defect;

Customised therapies;
Respiratory tract infection;
Inflammation in cystic fibrosis;
Clinical and epidemiological research.

Grants are worth up to €200,000 for three-year projects, €130,000 for two-year projects or €70,000 for one year. INDI coverage 7%.

Deadline: 31st of January 2025

US calls

Federal Funding

Notice of Special Interest (NOSI): Developing and Delivering Feasible Screening Methods and Tools for Eating Disorders.

Funding Opportunity ID: NOT-MH-24-380

Upcoming deadlines: October 15^th, 2024 to May 8^th, 2027

Abstract: The National Institute of Mental Health (NIMH) is issuing this Notice of Special Interest (NOSI) to encourage applications that investigate the development and delivery of screening methods for subthreshold and diagnosable eating disorders in naturalistic settings for children, adolescents, and adults. An emphasis is placed on research that seeks to develop and test low-burden, feasible screening methods, addresses inequities in detection among populations with health disparities, utilizes existing setting staff and/or lay/alternate providers to aid in screening efforts, aims to quantify the resources necessary to implement these approaches, and/or proposes to identify and address factors that hinder/facilitate implementation and scale-up.

Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)

Funding Opportunity ID: PAR-23-168

Upcoming deadlines: February 5^th, 2025; June 5^th, 2025; October 5^th, 2025

Abstract: The overarching goal of this Notice of Funding Opportunity (NOFO) is to support the development and validation of screening assays for the discovery of validated hits that can be used in future drug discovery/development efforts for identifying potential drug candidates for the treatment of mental illness. For purposes of this initiative, a hit is defined as a compound that has the desired activity in a compound screen and whose activity is confirmed upon retesting in orthogonal assays. Stages of discovery research covered by this NOFO include 1) assay development; 2) primary screen implementation to identify initial screening hits (high throughput target-focused screens, or moderate throughput screens); and 3) hit validation using a series of assays and initial medicinal chemistry inspection to prioritize the hit set.

Notice of Special Interest (NOSI): Advancing Precision Imaging for Enhanced Diagnosis and Treatment of Oral Lesions

Funding Opportunity ID: NOT-DE-25-034

Upcoming deadlines: October 5^th, 2024 to September 8^th, 2027

Abstract: This Notice of Special Interest (NOSI) is to encourage research projects to enhance accuracy, detection, diagnosis, and personalized treatment of oral lesions and inflammatory processes using advanced imaging technologies. By integrating cutting-edge imaging modalities into clinical workflows, optimizing lesion detection methods, and refining single-cell analysis, this NOSI seeks to bridge existing gaps in precision imaging for oral diseases. The long-term goal is to establish standardized quantitative imaging metrics, integrate imaging into clinical trials, and combine imaging data with multi-omics information for comprehensive profiling of oral lesions. Through collaborative research efforts, this NOSI strives to accelerate the translation of breakthrough discoveries in imaging into clinical applications, ultimately advancing the management of acute and chronic oral health conditions and improving patient outcomes.

Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

Funding Opportunity ID: PAR-23-164

Upcoming deadlines: February 5^th, 2025; June 5^th, 2025; October 5^th, 2025

Abstract: This Funding Opportunity Announcement (NOFO) invites research grant applications that propose the development and evaluation of novel radioligands for positron emission tomography (PET) or single photon emission computed tomography (SPECT) imaging in human brain and the incorporation of pilot or clinical feasibility evaluation from previously collected data in pre-clinical studies. These studies are expected to provide the requisite data needed to advance promising PET ligands for use in clinical research. Projects proposing only preclinical animal studies should consider the companion NOFO (PAR-23-164).

Foundation

Foundation Fighting Blindness (FFB), US – Individual Investigator Research Award/Clinical Innovation Award

Upcoming deadlines: LOI – 24^thOctober, 2024; Full application (by invitation) – 6^th March, 2025

Amount: Up to $300,000 over a 3 year period. Indirect costs are not allowable.

Eligibility: Applicants must hold a Ph.D., M.D., D.M.D., D.V.M., D.O., O.D., or equivalent degree and have a faculty position or equivalent at a domestic or foreign: non-profit organization, or public or private institution, such as a university, college, medical school, hospital, research institute, or laboratory.

Abstract: Individual Investigator Research Awards are designed to concentrate research in areas that will have the greatest potential to move towards treatments and cures for the inherited orphan retinal degenerative diseases and dry age-related macular degeneration (dAMD). While proposals addressing the areas of particular interest below will be given priority consideration, the FFB will also consider proposals for highly novel research that do not fit easily within these goals. Research Priority Areas: Genetic Technologies; Restorative Therapies (includes cell-based approaches, visual prosthetics and optogenetics); Novel Medical Therapies; Clinical: Structure and Function; Genetics; Cell and Molecular Mechanisms of Disease

Cystic Fibrosis Foundation (CFF), US – Gastrointestinal Manifestations of CF: Basic Science Projects

Upcoming deadlines: Full application – 5^th December, 2024

Amount: $450,000. Funding of up to $150,000 per year, plus an additional twelve percent (12%) of indirect costs may be requested. Awards may be approved for up to a three (3) year project period. Eligibility: Applicants must be independent investigators. Candidates who are clinical fellows should apply to the CFF Clinical Fellowship program for the appropriate year. Candidates who are postdoctoral fellows should apply to the CFF Postdoctoral Research Fellowship program. International applicants and institutions are required to submit additional information in accordance with USA Patriot Act and the U.S. Department of Treasury Anti-Terrorist Financing Guidelines.

Abstract: The intent of this request for applications is to solicit and fund projects that will improve our understanding of the biological basis for the development and progression of gastrointestinal manifestations in cystic fibrosis as well as to identify potential novel therapeutic strategies to manage and treat them.

CureSearch for Children's Cancer, US – CureSearch Acceleration Initiative Awards in Pediatric Cancer

Upcoming deadlines: LOI – 7^thOctober, 2024; Full application (by invitation) – 18^th January, 2025

Amount: $1,500,000 per year for 3 years. 10% indirect costs covered.

Eligibility: The applicant must be the principal investigator (PI). The PI must be an independent investigator at any level who is affiliated with an academic institution. Applications are open to applicants in North America, the European Union, Japan, the United Kingdom, China, and Australia. Non-U.S. applicants must comply with U.S. anti-terrorism financing laws. For applicants seeking support of $500,000 or greater, a minimum committed effort of 10% from the PI is required.

Abstract:The CureSearch for Children’s Cancer Acceleration Initiative (AI) advances pediatric cancer research worldwide to address the most challenging problems facing childhood cancer research in order to accelerate progress in the field toward a cure. CureSearch will review and fund promising research that addresses barriers in areas of high unmet need in pediatric cancer research. We support innovative, evidence-based translational and preclinical cancer research that has a high potential to improve therapeutic options through research pathways that are collaborative, interdisciplinary, and generate measurable results.

Leukemia & Lymphoma Society (LLS), US – Physician Scientist Fellow Award

Upcoming deadlines: LOI – 6^thNovember, 2024; Full application (by invitation) – 29^th January, 2025

Amount: Up to $170,000 over 2 years. Indirect costs are not covered by this grant.

Eligibility: Applicants must hold a MD; have completed or be in their last year of their fellowship in hematology, oncology, hematopathology, pathology, or other related disciplines; be enrolled in either a Master’s or PhD program, or as a post-doctoral fellow at the time of application; have a Sponsor (or Sponsor/co-Sponsor pair) that has significant experience in the blood cancer field; have a Sponsor with adequate funding that supports the research proposed; be on a clear trajectory to an independent career in hematology/oncology with a focus on blood cancer and clinical translation; have at least 50% protected time for research; and demonstrate the need for continued funding.

Abstract: The intent of the Physician Scientist Fellow Award is to encourage early-stage specialist clinicians to pursue a career in blood cancer research. The award is specifically targeted at MDs near, or recently at, the completion of specialty training in hematology, oncology, hematopathology, pathology, or other related disciplines and who have initiated or have immediate plans to begin supervised research training directed at blood cancers. This opportunity is designed to foster, through provision of a contribution to their salary, the acquisition of skills and independence to conduct research in blood cancers at the laboratory, clinical or combined levels.